Perseus Proteomics (TSE:4882) Interest Expense: 円-6.4 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4882 Perseus Proteomics Inc TSE:4882
56 GF Score
Price 円149.00
GF Value 円439.77
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Perseus Proteomics Interest Expense?

Perseus Proteomics TSE:4882 -5.70% 56 Interest Expense is 円-6.4 Mil as of Mar. 2026. GuruFocus rates TSE:4882 with a GF Score™ of 56/100 and a GF Value™ of 円439.77 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Perseus Proteomics's interest expense for the six months ended in Mar. 2026 was 円 -6.4 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was 円-6.4 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Perseus Proteomics's Operating Income for the six months ended in Mar. 2026 was 円 -345.2 Mil. Perseus Proteomics's Interest Expense for the six months ended in Mar. 2026 was 円 -6.4 Mil. Perseus Proteomics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Perseus Proteomics  (TSE:4882) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Perseus Proteomics's Interest Expense for the six months ended in Mar. 2026 was 円-6.4 Mil. Its Operating Income for the six months ended in Mar. 2026 was 円-345.2 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Mar. 2026 was 円0.0 Mil.

Perseus Proteomics's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Perseus Proteomics did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Perseus Proteomics Interest Expense Historical Data

* Premium members only.

The historical data trend for Perseus Proteomics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Perseus Proteomics Interest Expense Chart

Perseus Proteomics Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Interest Expense
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 -5.53 -0.96 -6.40

Perseus Proteomics Semi-Annual Data
Mar18 Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.53 -0.96 0.00 -0.03 -6.37
TSE:4882
56GF Score
Perseus Proteomics Inc TSE:4882
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Perseus Proteomics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円-6.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of 円-6.4 Mil mean?
Perseus Proteomics (TSE:4882) has a Interest Expense of 円-6.4 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Perseus Proteomics and its competitors.
Is Perseus Proteomics' Interest Expense too high?
Perseus Proteomics' current Interest Expense is 円-6.4 Mil. Overall, Perseus Proteomics has a GF Score™ of 56/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Perseus Proteomics' Interest Expense compare to LLY and JNJ?
Perseus Proteomics' Interest Expense of 円-6.4 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Perseus Proteomics and its competitors. Perseus Proteomics's current Interest Expense is 円-6.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perseus Proteomics stock overvalued right now?
Based on GuruFocus' analysis, Perseus Proteomics (TSE:4882) is currently considered Significantly Undervalued. The stock's GF Value™ is 円439.77, compared to a current price of 円149.00 — trading 66.1% below its estimated fair value. The current Interest Expense is 円-6.4 Mil. Perseus Proteomics' overall GF Score™ is 56/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Perseus Proteomics (TSE:4882), the current Interest Expense is 円-6.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Perseus Proteomics (TSE:4882) Overvalued in 2026?

Based on GuruFocus' analysis, Perseus Proteomics stock appears to be undervalued. The current stock price of 円149.00 is trading 66.1% below its estimated GF Value™ of 円439.77. GuruFocus considers Perseus Proteomics to be Significantly Undervalued.

Key valuation signals for TSE:4882:

  • Interest Expense: 円-6.4 Mil
  • GF Value™: 円439.77 vs. price of 円149.00 (66.1% below fair value)
  • GF Score™: 56/100 with 1 warning sign

No single metric tells the full story. See the TSE:4882 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Perseus Proteomics Business Description

Address 30-1 Hakozakicho, Nihonbashi, Chuo-ku, AiNihombashi EAST 3rd floor, Tokyo, JPN, 103-0015
Perseus Proteomics Inc is engaged in the research and development, manufacture, and sales of pharmaceuticals. It provides antibody-based therapeutics and diagnostic drugs to cure cancer and other diseases. The Company operates in a single segment, the pharmaceutical business.
56GF Score

Get the complete analysis for TSE:4882

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円149.00
Price
円439.77
GF Value